Cited 78 times in
Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.